Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP
- 8 February 2005
- journal article
- research article
- Published by Elsevier BV in Brain Research
- Vol. 1033 (2), 216-220
- https://doi.org/10.1016/j.brainres.2004.11.040
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Endogenous Activation of mGlu5 Metabotropic Glutamate Receptors Contributes to the Development of Nigro-Striatal Damage Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in MiceJournal of Neuroscience, 2004
- Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sitesProceedings of the National Academy of Sciences of the United States of America, 2003
- Changes in dialysate concentrations of glutamate and GABA in the brain: an index of volume transmission mediated actions?Journal of Neurochemistry, 2003
- Selective Blockade of mGlu5 Metabotropic Glutamate Receptors Is Protective against Methamphetamine NeurotoxicityJournal of Neuroscience, 2002
- Group I mGluR antagonist AIDA protects nigral DA cells from MPTP-induced injuryNeuroReport, 2001
- Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processesJournal of Neurochemistry, 2001
- 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonistNeuropharmacology, 1999
- Some new, simple and efficient stereological methods and their use in pathological research and diagnosisAPMIS, 1988